Home > Insider Trading > Filing (0001104659-16-130859)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1491576	Tesaro Inc.	TSRO	Pharmaceutical Preparations (2834)	272249687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646448	H. Jeffrey Hanke	C/O Tesaro, Inc. 1000 Winter Street Suite 3300 Waltham MA 02451	Executive Vp, R&D And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-06-30	12,500	$0.00	12,500	No	4	M	Direct
Common Stock	Disposition	2016-06-30	2,800	$73.43	9,700	No	4	S	Direct
Common Stock	Disposition	2016-06-30	9,700	$74.61	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2016-06-30	12,500	$0.00	50,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
38,500			No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2015.
The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $73.15 to $73.97, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $74.03 to $75.00, inclusive. The reporting person undertakes to provide to TESARO, Inc., any security holder of TESARO, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Each restricted stock unit represents a contingent right to receive one share of TSRO common stock.
The restricted stock units vest in four equal annual installments beginning June 29, 2016. Vested shares will be delivered to the reporting person within 30 days of the applicable vesting date.